|
|
||||
Kimberly
E.
Foreman, Ph.D.
|
|
|||
|
Research in our laboratory focuses on Notch signaling in human malignancies, particularly breast cancer. Activated Notch is found in breast cancer tissue samples, and over expression of Notch receptors and ligands in breast cancer is associated with a poor prognosis. These findings suggest Notch may play an important role in breast cancer tumorigenesis, and Dr. Foreman's laboratory is working from the hypothesis that Notch signaling is a potential therapeutic target for cancer treatment. Currently, her laboratory is focused on two areas of investigation: Notch signaling and angiogenesis; Notch signaling in breast tumor initiating cells (also referred to as cancer stem cells). Selected PublicationsCurry CL, Reed LL, Broude E, Golde TE, Miele L, and KE Foreman. (2007). Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol Cancer Ther. 2007 Jul;6(7):1983-92. Curry, CL, LL Reed, L Miele, BJ Nickoloff, and
KE Foreman (2006).. Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase (JNK) signaling in human endothelial cells.
Laboratory Investigation. 8:842-852 Search PubMed for a complete listing of Kimberly Foreman's publications. / SSOM / Loyola University Chicago / LUHS / Contact Us
©1995-2009
Loyola University Chicago Stritch School of Medicine. |
||||